FcγRIIB as a key determinant of agonistic antibody efficacy.
about
Influence of immunoglobulin isotype on therapeutic antibody functionDissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.Special Conference on Tumor Immunology and Immunotherapy: A New Chapter.Kaposi sarcoma-associated herpesvirus latency locus renders B cells hyperresponsive to secondary infectionsStructure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
P2860
FcγRIIB as a key determinant of agonistic antibody efficacy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
FcγRIIB as a key determinant of agonistic antibody efficacy.
@en
type
label
FcγRIIB as a key determinant of agonistic antibody efficacy.
@en
prefLabel
FcγRIIB as a key determinant of agonistic antibody efficacy.
@en
P1476
FcγRIIB as a key determinant of agonistic antibody efficacy.
@en
P2093
Ann L White
Stephen A Beers
P304
P356
10.1007/978-3-319-07911-0_16
P50
P577
2014-01-01T00:00:00Z